Search - tctmd.com

Displaying 21 - 40 of 50

Sort: Relevancy | Date

Presentation SOLACI 2017

Is the PCI risk higher in patients with severe aortic stenosis? How can we reduce the risk?

Presenter: Daniel Weilenmann

August 02, 2017

Presentation SOLACI 2017

Role of general anesthesia during TAVI

Presenter: Andreas Baumbach

August 02, 2017

News Industry News

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

August 01, 2017

News Daily News

Delirium’s Dangers Following TAVR: More Evidence

Shelley Wood

July 19, 2017

Presentation

Temporal Trends in TAVR: From FRANCE 2 (2010-2012) to FRANCE TAVI (2013-2015)

June 26, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

Presentation TVT 2017

A Friendly Tie on a Hard TAVI

Presenter: David W.M. Muller, Lars Sondergaard, Roman Lezaun, MD

June 16, 2017

Presentation TVT 2017

Looping Against TAVI Leaks: The Magic Tool

Presenter: David W.M. Muller, Lars Sondergaard, Roman Lezaun, MD

June 16, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

Spotlight Lecture: The Rapid Emergence of TAVR Programs in Japan - The OCEAN-TAVI Registry

Presenter: Robert O. Bonow, Martin B. Leon, Kentaro Hayashida

June 15, 2017

Presentation TVT 2017

TAVI for Moderate Aortic Stenosis in Cardiogenic Shock and Inotrope Dependence

Presenter: Albert Markus Kasel, Thomas Walther, Hasan Ahmad, MD

June 15, 2017

Presentation EuroPCR 2017

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

Presenter: Luca Testa

May 19, 2017

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

Shelley Wood

May 18, 2017

News Conference News EuroPCR 2017

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Yael L. Maxwell

May 17, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Shelley Wood

May 16, 2017

News Industry News

Boston Scientific Closes Symetis Acquisition

May 16, 2017

News Industry News

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

May 15, 2017

News Daily News

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

Caitlin E. Cox

April 21, 2017

Advertisement

Is the PCI risk higher in patients with severe aortic stenosis? How can we reduce the risk?

Role of general anesthesia during TAVI

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

Delirium’s Dangers Following TAVR: More Evidence

Temporal Trends in TAVR: From FRANCE 2 (2010-2012) to FRANCE TAVI (2013-2015)

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

A Friendly Tie on a Hard TAVI

Looping Against TAVI Leaks: The Magic Tool

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Spotlight Lecture: The Rapid Emergence of TAVR Programs in Japan - The OCEAN-TAVI Registry

TAVI for Moderate Aortic Stenosis in Cardiogenic Shock and Inotrope Dependence

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

More Early Stroke With SAVR Than TAVR in SURTAVI

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Boston Scientific Closes Symetis Acquisition

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content